SEOM clinical guidelines in early stage breast cancer (2018)

• DOI: 10.1007/s12094-018-1973-6
• Publication Date: 2018-11-15T08:03:11Z
• Authors: F. Ayala de la Peña; R. Andrés; J. A. Garcia-Sáenz; L. Manso; M. Margelí; E. Dalmau; S. Pernas; A. Prat; S. Servitja; E. Ciruelos
• Keywords: Systemic therapy

Breast cancer is the most common in women our country and it usually diagnosed early potentially curable stages. Nevertheless, around 20–30% of patients will relapse despite appropriate locoregional systemic therapies. A better knowledge this disease improving ability to select therapy for each patient with a recent diagnosis an stage breast cancer, minimizing unnecessary toxicities long-term efficacy.